» Articles » PMID: 35163361

Therapeutic Potential of Human Fetal Mesenchymal Stem Cells in Musculoskeletal Disorders: A Narrative Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Feb 15
PMID 35163361
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic approach for diverse diseases and injuries. The biological and clinical advantages of human fetal MSCs (hfMSCs) have recently been reported. In terms of promising therapeutic approaches for diverse diseases and injuries, hfMSCs have gained prominence as healing tools for clinical therapies. Therefore, this review assesses not the only biological advantages of hfMSCs for healing human diseases and regeneration, but also the research evidence for the engraftment and immunomodulation of hfMSCs based on their sources and biological components. Of particular clinical relevance, the present review also suggests the potential therapeutic feasibilities of hfMSCs for musculoskeletal disorders, including osteoporosis, osteoarthritis, and osteogenesis imperfecta.

Citing Articles

Promotion of Bone Formation in a Rat Osteoporotic Vertebral Body Defect Model via Suppression of Osteoclastogenesis by Ectopic Embryonic Calvaria Derived Mesenchymal Stem Cells.

Yu Y, Lee S, Bock M, An S, Shin H, Rim J Int J Mol Sci. 2024; 25(15).

PMID: 39125746 PMC: 11311643. DOI: 10.3390/ijms25158174.


Stable Housekeeping Genes in Bone Marrow, Adipose Tissue, and Amniotic Membrane-Derived Mesenchymal Stromal Cells for Orthopedic Regenerative Medicine Approaches.

Ragni E, Piccolo S, Papait A, De Luca P, Taiana M, Grieco G Int J Mol Sci. 2024; 25(3).

PMID: 38338737 PMC: 10855448. DOI: 10.3390/ijms25031461.


Beyond Vision: An Overview of Regenerative Medicine and Its Current Applications in Ophthalmological Care.

Santa Cruz-Pavlovich F, Bolanos-Chang A, Del Rio-Murillo X, Aranda-Preciado G, Razura-Ruiz E, Santos A Cells. 2024; 13(2).

PMID: 38247870 PMC: 10814238. DOI: 10.3390/cells13020179.


Bio-Enhanced Neoligaments Graft Bearing FE002 Primary Progenitor Tenocytes: Allogeneic Tissue Engineering & Surgical Proofs-of-Concept for Hand Ligament Regenerative Medicine.

Jeannerat A, Meuli J, Peneveyre C, Jaccoud S, Chemali M, Thomas A Pharmaceutics. 2023; 15(7).

PMID: 37514060 PMC: 10385025. DOI: 10.3390/pharmaceutics15071873.

References
1.
Fan Y, Herr F, Vernochet A, Mennesson B, Oberlin E, Durrbach A . Human Fetal Liver Mesenchymal Stem Cell-Derived Exosomes Impair Natural Killer Cell Function. Stem Cells Dev. 2018; 28(1):44-55. DOI: 10.1089/scd.2018.0015. View

2.
Banfi A, Bianchi G, Notaro R, Luzzatto L, Cancedda R, Quarto R . Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng. 2003; 8(6):901-10. DOI: 10.1089/107632702320934001. View

3.
Gotherstrom C, Ringden O, Tammik C, Zetterberg E, Westgren M, Le Blanc K . Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol. 2004; 190(1):239-45. DOI: 10.1016/j.ajog.2003.07.022. View

4.
ODonoghue K, Chan J . Human fetal mesenchymal stem cells. Curr Stem Cell Res Ther. 2008; 1(3):371-86. DOI: 10.2174/157488806778226768. View

5.
Wang B, Lee W, Huang B, Zhang J, Wu T, Jiang X . Secretome of Human Fetal Mesenchymal Stem Cell Ameliorates Replicative Senescen. Stem Cells Dev. 2016; 25(22):1755-1766. DOI: 10.1089/scd.2016.0079. View